Glucocorticoids, which are widely used as anffinflammatory agents, downregulate the expression of the interleukin 6 gene and of additional cytokine genes involved in inflammatory responses. Conversely, the transcription factor NF-ucB, a member ofthe Rel family oftranscription factors, has been implicated in the induction of multiple genes involved in the early processes of immune and inflammatory responses. This prompted us to investigate whether one of the mechanisms by which glucocorticoids exert their aninflammatory activities is through inhibition ofgene activation mediated by NF-KB. We report that, in intact cells, activation of the interieukin 6
antiinflammatory properties of glucocorticoids in vivo.
Glucocorticoids strongly repress interleukin 6 (IL-6) gene expression induced by cytokines and by activators of protein kinases A and C (1-4) . Glucocorticoids synergize with IL-6 in increased hepatic synthesis of acute-phase plasma proteins (5-7) while inhibiting, via a negative feedback loop, uncontrolled production of IL-6 and other cytokines.
Previous studies in this laboratory established a requirement for wild-type glucocorticoid receptor (GR) for efficient repression of IL-6 gene expression induced by 8) . Although footprinting studies with the DNA-binding domain of GR revealed binding across the enhancer and basal promoter elements in the IL-6 gene, only weak binding by the intact wild-type GR to the IL-6 promoter was found, suggesting that a combination of DNA-binding and proteinprotein interactions may be responsible for efficient downregulation of IL-6 gene expression (8). Repression of the collagenase promoter, the proliferin promoter, and synthetic AP-1 site-chloramphenicol acetyltransferase (CAT) gene constructs by glucocorticoids was shown to be due to interactions between GR and the AP-1 site-binding protein . It seems unlikely that Fos/Jun-GR interactions play a significant role in the repression of the IL-6 gene by glucocorticoids, since MRE I (multiple cytokine-and second messenger-responsive enhancer I, nucleotides -173 to -151) in the IL-6 gene, which contains an AP-1-like sequence, is not a major contributor to IL-1 induction of the IL-6 gene (1). Two overlapping enhancer sequences, MRE I and MRE II The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (-158 to -145) in the IL-6 promoter, when independently linked to heterologous promoters, confer responsiveness to different stimuli (1, 13). MRE II was described as the binding site for nuclear factor NF-IL6 and hypothesized to be responsible for induction of the IL-6 gene by . Although the NF-KB site in the IL-6 gene (-64 to -73) was previously implicated in IL-6 gene expression (15, 16) , the presence of this site alone in IL-6 promoter constructs fails to activate the reporter gene (17, 18) .
The transcriptionally active NF-KB contains a 65-kDa subunit (p65) that forms a heterodimer with a 50-kDa subunit (p5O) (19, 20) . Contrary to earlier reports, it has been shown that p65 directly contacts DNA in a heterodimer with p5O (21-23) and that even p65 homodimers can bind DNA (21, 22) . The existence of p65 homodimers in vivo is yet to be demonstrated. Both DNA-binding and dimerization properties of the NF-KB subunits reside in a domain of -300 amino acids which is also found in proteins of the Rel family (24). p49/plOO, which can be derived by processing of the precursor protein plOO or by alternative splicing, shares a 60% identity in sequence with p105, the precursor of p5O (25, 26) . There is increasing evidence that the subunits singly may have independent modes of transactivation (22, 23, 27) .
In the present study, we have examined the role of NF-KB in IL-i-induced IL-6 gene expression. Due to the strikingly opposite roles ofNF-KB and glucocorticoids in inflammation, we have investigated the possibility offunctional antagonism between NF-KB and GR in repression of IL-i-activated expression of the IL-6 gene by glucocorticoids (1, 8) .
MATERIALS AND METHODS
Cell Culture and Transfections. HeLa human cervical carcinoma cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (17). F9 mouse embryonal carcinoma cells were plated on gelatin-coated plates and were maintained in DMEM with 15% fetal bovine serum. Transfections and CAT assays were essentially as described (1, 8) .
Plasmids. The construct pIC225 was described previously (17) . The NF-IL-6 site (MRE II; refs. 1 and 8) and the NF-KB site in pIC225 were mutated by site-directed mutagenesis (Muta-Gene, Bio-Rad). pmMRE Ilb225, containing mutations in the NF-IL6 site, was constructed in two steps using two different oligonucleotides sequentially: (i) 5'-CGTCACATcaCACAATCT-3' (mMRE Ila) and (ii) 5'-CGTCACATcaCAaAcaCTTAATAAGG-3' (mMRE IIb). The oligonucleotide 5'-TTTATCAAATGTaatATTTTCCCATGA-3' was used to construct pmNF-KB225. The cDNAs for p49 or p65 in Bluescript plasmids or under the control of the Rous sarcoma virus (RSV) promoter (pRSV49 or pRSV65) were Abbreviations: IL-n, interleukin n; GR, glucocorticoid receptor; MRE, multiple cytokine-and second messenger-responsive enhancer; CAT, chloramphenicol acetyltransferase; RSV, Rous sarcoma virus; MTV, mammary tumor virus; CMV, cytomegalovirus.
*To whom reprint requests should be addressed. by fusion of an ATG codon in frame to amino acid 141, and the resulting fragment containing amino acids 141-296 of the protein was subcloned into pGEM-7Zf(+) (Promega) for expression under the control of the T7 promoter. A cDNA fragment encoding GRAS, comprising amino acids 1-5% of human GR, was subcloned into pGEM-4Z (Promega).
Electrophoretic Mobility-Shift Assays. In vitro translated p49 or p65 was incubated with the NF-KB probe in 20 ,ul of reaction mixture containing 20 mM Hepes (pH 7.9), 50 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 0.5% (vol/vol) Nonidet P-40, 5% (vol/vol) glycerol, 1 mM phenylmethanesulfonyl fluoride, 0.5 ,ug of poly(dI-dC), and 1 pg of bovine serum albumin. The following is the sequence of the doublestranded oligonucleotide probe used in the assay (the NF-KB site of the IL-6 gene is in bold type).
5'-TCGAAATGTGGGATTTTCCCATGAGT-3' 3'-TTACACCCTAAAAGGGTACTCACTAG-5' For competition experiments, the unlabeled oligonucleotides were used at a 50-fold molar excess.
Crosslinking and Immunoprecipitations. For protein crosslinking and immunoprecipitations, proteins were synthesized in vitro with the TNT system (Promega) using [35S]methionine or unlabeled amino acids. Individual lysates were appropriately mixed and incubated in 20 mM Hepes, pH 7.9/50 mM KCl/2.5 mM MgCl2/1 mM dithiothreitol/l mM phenylmethanesulfonyl fluoride/10%o glycerol with aprotinin at 10 pg/ml for 30 min at room temperature. The proteins were crosslinked with dithiobis(succinimidyl propionate) (5 mM) for 15 min at room temperature and the reaction was terminated by addition of ethanolamine to 0.1 M. The crosslinked proteins were diluted to 200 Al with a modified radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris HCl, pH 7.5/150 mM NaCl/2 mM EDTA/0.5% sodium deoxycholate/0.5% Nonidet P-40/0.1 M ethanolamine/1 mM phenylmethanesulfonyl fluoride with aprotinin at 10 ug/ml), precleared, and subjected to immunoprecipitation with anti-GR antibody (gift of W. Hoeck, Syntex Research) or anti-p65 antibody (Santa Cruz Biotechnology). Coimmunoprecipitation of GR/p65 complexes from metabolically labeled cells was carried out by procedures described in ref. 29 .
RESULTS
Activation of the IL-6 Promoter Requires both NF-HL6 and NF-KB Binding Sites. Earlier studies have established that 225 bp of 5' flanking sequences ofthe IL-6 gene linked to the CAT gene (pIC225) is sufficient for conferring IL-1 response on the IL-6 promoter (1, 13). The construct pIC110, which contains 110 bp of IL-6 gene 5' flanking sequence including the NF-KB site between -64 and -73, is, however, not induced by IL-1 or by additional stimuli (1, 13, 17, 18) . In view of the implication of this NF-KB site in the induction of the IL-6 gene (15, 16), we explored the IL-1-inducibility of constructs pmMRE IIb225 and pmNF-KB225, mutated at the NF-IL6-binding site MRE II and the NF-KB site, respectively (Fig. 1) (Dex, 1 , uM) . Cells were grown, harvested, and assayed for 3-galactosidase and CAT activity as in Fig. 1 diminished in HeLa cells (Fig. 1A ). To further demonstrate that the activation of pIC225 depends on the presence of both the MRE II and NF-KB sites, we performed a similar experiment in undifferentiated F9 embryonal carcinoma cells. F9 cells lack endogenous NF-IL6 (7), AP-1 (9), and possibly also Rel-like activities (30) and are therefore the cells of choice when investigating the role of the particular transcription factors in gene expression. No pIC225 expression was detected with any of the singly cotransfected expression vectors in F9 cells (Fig. 1A) . Only a combination of the expression vectors CMVNF-IL6 and pRSV65 yielded a 10-fold increase in CAT expression over basal expression (Fig. 1A) . Interestingly, coexpression of p49, the processed product of plOO, similar to p5O of NF-KB, completely inhibited the increased CAT expression obtained by a combination of pRSV65 and CMVNF-IL6 (Fig. 1A) . The p5O subunit of NF-KB was recently shown to interact with NF-IL6, although the functional significance of this association was not addressed (31). The inhibition of NF-IL6/p65-mediated activation of the IL-6 promoter by overexpression of p49 may be due to sequestration of p65 and NF-IL6 by p49. We have not determined the effect of coexpression of p5O on IL-6 promoter activity, either alone or in combination with other transcription factors. Expression vectors for Fos/Jun and NF-IL6 or Fos/Jun and p49/p65, in all possible combinations, had no effect on CAT expression from pIC225 (data not shown).
Functional Antagonism Between GR and p65 and Inhibition of DNA-Binding Activity of p65 by GR. Having established that NF-IL6 and p65 are required for activation of the IL-6 promoter, we examined the possibility that repression by glucocorticoids might be achieved by association of one of these proteins with GR. We cotransfected combinations of expression vectors for various transcription factors and GR in HeLa cells and asked whether GR was able to inhibit activation of pIC225 by NF-IL6 and p65. In contrast to what was observed in F9 cells, in HeLa cells, expression of either one of these factors could elicit CAT expression ( Fig. 2A) . This may be due to the interaction of NF-IL6 or p65 with endogenous transcription factors interacting with other motifs in the IL-6 promoter such as MRE I (1, 13). GR and dexamethasone only partially repressed activation of pIC225 by NF-IL6 alone in HeLa cells ( Fig. 2A) , in contrast to their total repression of IL-1-induced IL-6 gene expression, observed in these and earlier studies (1, 8) . However, the fact that activation by p65 of pIC225 was reduced to basal levels by GR and dexamethasone ( Fig. 2A) suggested that p65 might be a target of GR. Similar transfection experiments in F9 cells with 2.5 jig each ofcoexpressed NF-IL6 and p65 vectors gave about 70% inhibition with a combination of GR (5 jig) and dexamethasone (Fig. 2) . This inhibition could be titrated down to almost basal levels by increasing the ratio of GR to CMVNF-IL6 and pRSV65 (data not shown).
To investigate whether GR affected the binding of p65 to the IL-6 KB oligonucleotide probe, proteins synthesized in reticulocyte lysates in the presence of [35S]methionine were tested in electrophoretic mobility shift assays. GR expressed in vitro which lacked the steroid-binding domain is referred to as GRAS. This receptor construct retained (i) the two zinc fingers, which are required for its repressor function on the IL-6 promoter (1, 8) and the AP-1 site (9-12), and (ii) the adjacent putative amphipathic helix that has been proposed to be involved in protein-protein interactions (32).
In contrast to p49, p65 bound very strongly to the probe (Fig. 2B) . p49 also binds weakly to the KB site in the human immunodeficiency virus enhancer (26). Holding the level of p65 constant in lanes 2, 4, and 6, and increasing the amount of GRAS approximately 1-, 2-, and 3-fold over p65, incrementally inhibited the DNA-binding ability of p65 (Fig. 2B) . Densitometric scanning ofthe autoradiograph revealed a 65% reduction in the ability of p65 to bind DNA in the presence of excess (3-fold) GRAS. GRAS alone did not bind to the probe (Fig. 2B, lanes 1, 3, and 5) . Preincubation of excess GRAS with p65 resulted in significant but not complete inhibition of the DNA-binding ability of p65; the reason for partial inhibition is probably due to competition from endogenous NF-KB-like activity present in rabbit reticulocyte extracts (33). In a recent report, Nishio et al. (7) demonstrated interaction between GR and the basic-leucine zipper domain of NF-IL6 in coimmunoprecipitation experiments (7). However, their attempts to detect such an interaction by means of gel shift assays were not successful.
Direct Physical Interaction Between p65 and GR. To investigate the possibility that the antagonism between GR and p65 Proc. Natl. Acad. Sci. USA 91 (1994) Proc. Natl. Acad. Sci. USA 91 (1994) on inclusion of protease inhibitors such as aprotinin (10 ,ug/ml) and phenylmethanesulfonyl fluoride (1 mM) to the in vitro translation reactions (see Fig. 4 ).
The immunoprecipitates were washed extensively before crosslinks were reduced by boiling in 2x SDS/PAGE sample buffer containing 10%t
(vol/vol) 2-mercaptoethanol. The products were resolved in an SDS/15% polyacrylamide and the gel was subjected to fluorography and autoradiography. or truncated murine NF-IL6 (ANF-IL-6, containing amino acids 141-2%) was incubated with 10 Sd of unlabeled GRAS, crosslinked with 5 mM dithiobis(succinimidyl propionate), and immunoprecipitated with anti-GR antibody. The reaction mixtures were further processed as above.
might be due to direct association, we tested whether the proteins in solution could be chemically crosslinked. Due to the similar molecular sizes of p65 and GRAS, in experiments utilizing both (Fig. 3 A and B) , only one was labeled. In one set of experiments, cell-free translated p65 was labeled with [35S]methionine while similarly synthesized GRAS was left unlabeled. After the two proteins were incubated together and crosslinked with dithiobis(succinimidyl propionate), the mixture was divided into two parts. One part was treated with control rabbit nonimmune serum and the other part was immunoprecipitated with anti-GR antiserum. After reversal of crosslinks by reduction, the proteins were analyzed by SDS/PAGE. Fig. 3A shows specific immunoprecipitation of p65 with the receptor-specific antiserum and not the control serum. In the reciprocal experiment, the ability of anti-p65 antiserum to precipitate [35S] methionine-labeled GRAS when coincubated with unlabeled p65 was studied. Fig. 3B illustrates that the p65 specific band can be detected only with the specific antiserum. The anti-p65 antiserum was not very efficient for quantitative immunoprecipitations, most probably owing to its anti-peptide nature. In similar experiments, we failed to detect any association between GRAS and either p49 or ANF-IL6 (Fig. 3C) . We also asked whether a complex between GR and p65 can form in intact cells. To enhance our chances of detecting such an interaction in cell lysates, HeLa cells were transfected with expression vectors for full-length GR and p65 and cells were cultured in methionine-free medium supplemented with 135S]methionine. A nuclear extract was prepared from these cells for a double immunoprecipitation. A part of the extract was split into two equal parts and immunoprecipitation was performed in two steps with each part. Anti-GR antiserum, and not nonimmune serum, specifically coimmunoprecipitated a protein that when released from the complex was again specifically recognized by anti-p65 antibody (Fig. 4) . The '100-kDa nonspecific band seen in both lanes when anti-GR antiserum was used as the first antibody was reproducibly detected and was not further characterized.
p65 Represses GR-Mediated Activation. The experiments illustrated in Figs. [2] [3] [4] suggested that GR could interact with p65 to inhibit its activity. In the event of such an interaction, it was also possible that p65 would inhibit the ability of GR to activate transcription. The experiment illustrated in Fig. 5 confirms this hypothesis. In HeLa cells, under our transfection conditions, wild-type GR is a potent hormone-dependent activator of the mouse MTV long terminal repeat. Cotransfection of pRSV65 inhibited the GR-dependent activation of pMTV-CAT. This inhibition was p65-specific and not due to cross-competition for common transcription factors between the RSV and MTV promoters, since cotransfection with pRSV49 had no effect on transactivation of the MTV promoter by GR and dexamethasone (Fig. 5 true physiological inhibitor of IL-6 gene expression and, since p49 is a closely related homolog of p50, whether p50 is also inhibitory for IL-6 gene expression. If indeed such is the case, in response to IL-1, p65 will need to selectively interact with NF-IL6 to activate the IL-6 promoter. Possible mechanisms by which this might be achieved are posttranslational modifications or enhanced transcription of p65 by IL-1. An inhibition of p49/p5O activity (if both have inhibitory properties on the IL-6 promoter) is also a possibility. A negative effect of p50 on p65-mediated activation of a reporter construct driven by two NF-KB sites was reported (27).
Our present results extend previous studies on mechanisms of repression of the IL-6 promoter by GR (1, 8) by demonstrating physical association between GR and p65. A possible explanation for our failure to detect an interaction between GR and NF-IL6, as reported by Nishio et al. (7), is that the complex was unstable under our assay conditions. In the present study, while activation of the IL-6 promoter by NF-IL6 alone was only partially repressed by GR and dexamethasone, that by p65 was totally inhibited (Fig. 2A) . This suggests that inhibition of p65 activity may be a key mechanism for efficient repression of IL-6 gene expression induced by IL-1 and perhaps by additional stimuli.
In earlier studies, although intact GR did not bind as avidly to IL-6 sequences as to the glucocorticoid response element present in the MTV promoter (8), its DNA-binding domain was important for repressor function in functional studies (1, 8) . This observation was not entirely surprising, since the DNA-binding domain of GR is also important for repression of Jun/AP-1 function, although DNA-binding activity itself is apparently not necessary for repression (11, 12) . In this role, the DNA-binding domain may be responsible for a dimerization function rather than for a DNA-binding function. These observations suggest that the DNA-binding domain is also involved in protein-protein interactions with p65/NF-IL6.
This mechanism of inhibition by GR by antagonism of p65 activity bypasses the need for a negative glucocorticoid response element for efficient repression by glucocorticoids. The mechanism does not rule out the possibility that a combination of DNA-binding and protein-protein interactions accounts for the total repression of IL-6 gene expression by glucocorticoids. Thus, regulation of IL-6 gene expression is an excellent example of how cross-coupling of distinct pathways (NF-IL6 and NF-KB) in certain situations can activate gene transcription and in others (GR and NF-KB) can repress gene expression. The reciprocal functional antagonism between p65 and GR provides a framework for the opposing actions of inflammatory mediators and steroids.
